Open for inclusion

A Phase I/II Study of 177Lu-HH1 (Betalutin®) Radioimmunotherapy for Treatment of Relapsed Non-Hodgkin Lymphoma

Cancer type: Lymphoma

Phase: I/II

Principal Investigator: Kolstad Arne

Country: NO

Keywords: Relapsed Non-Hodgkin Lymphoma, Radioimmunotherapy, Oslo, Bergen, Trondheim, Linköping, Borås, Umeå, Norway, Sweden

Status: Open for inclusion

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT01796171?term=LYMRIT+37-01&rank=1